HCPCS drug code · CMS crosswalk
Ondansetron HCl HCPCS Code
In short
CMS assigns Ondansetron HCl NDCs to 2 HCPCS codes: J2405 (per 1 mg), Q0162 (per 1 mg). Which one applies depends on the product; the table lists each NDC with its code.
Reference
- J2405
- Injection, ondansetron hydrochloride, per 1 mgBilling unit: 1 mg
- Q0162
- Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimenBilling unit: 1 mg
- Labelers
- A-S Medication Solutions; Accord Healthcare Inc; American Health Packaging; Apotex Corp; Athenex Pharmaceutical Division, LLC; AvPAK; Baxter Healthcare Corporation; Chartwelland 15 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Ondansetron HCl units and claim line
Enter the dose given to get the J2405 units and the NDC line for the CMS-1500 and the 837P. This builds the J2405 line; use the code page for Q0162.
Enter the dose given to build the claim line.
Ondansetron HCl NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00404-9930-02 | J2405 | Henry Schein Inc. | 2 | 4 |
| 00409-0009-25 | J2405 | Pfizer Inc | 25 × 2 | 100 |
| 00409-2271-25 | J2405 | Pfizer Inc | 25 × 2 | 100 |
| 00409-4755-03 | J2405 | Pfizer Inc | 25 × 2 | 100 |
| 00409-4759-01 | J2405 | Pfizer Inc | 20 | 40 |
| 00641-6078-25 | J2405 | Hikma Pharmaceuticals USA Inc. | 25 × 2 | 100 |
| 00641-6079-01 | J2405 | Hikma Pharmaceuticals USA Inc. | 20 | 40 |
| 00641-6080-25 | J2405 | Hikma Pharmaceuticals USA Inc. | 25 × 2 | 100 |
| 00641-6286-01 | J2405 | Hikma Pharmaceuticals USA Inc. | 20 | 40 |
| 16729-0298-05 | J2405 | Accord Healthcare Inc | 20 | 40 |
| 23155-0547-42 | J2405 | Heritage Pharmaceuticals Inc. | 25 × 2 | 100 |
| 23155-0548-42 | J2405 | Heritage Pharmaceuticals Inc. | 25 × 2 | 100 |
| 23155-0549-31 | J2405 | Heritage Pharmaceuticals Inc. | 20 | 40 |
| 23155-0550-31 | J2405 | Heritage Pharmaceuticals Inc. | 20 | 40 |
| 25021-0777-02 | J2405 | Sagent Pharmaceuticals | 25 × 2 | 100 |
| 36000-0012-25 | J2405 | Baxter Healthcare Corporation | 25 × 2 | 100 |
| 51662-1245-01 | J2405 | HF Acquisition Co. LLC, DBA HealthFirst | 2 | 4 |
| 51662-1245-03 | J2405 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 2 | 100 |
| 51662-1377-01 | J2405 | HF Acquisition Co. LLC, DBA HealthFirst | 20 | 40 |
| 60505-6130-05 | J2405 | Apotex Corp | 25 × 2 | 100 |
| 63323-0373-02 | J2405 | FreseniUS Kabi USA, LLC | 25 × 2 | 100 |
| 63323-0374-20 | J2405 | FreseniUS Kabi USA, LLC | 20 | 40 |
| 65219-0323-02 | J2405 | FreseniUS Kabi USA, LLC | 25 × 2 | 100 |
| 70860-0776-02 | J2405 | Athenex Pharmaceutical Division, LLC | 25 × 2 | 100 |
| 70860-0777-21 | J2405 | Athenex Pharmaceutical Division, LLC | 10 × 20 | 400 |
| 72266-0123-25 | J2405 | Fosun Pharma USA Inc. | 25 × 2 | 100 |
| 72266-0124-01 | J2405 | Fosun Pharma USA Inc. | 20 | 40 |
| 72572-0520-25 | J2405 | Civica, Inc. | 25 × 2 | 100 |
| 76045-0216-20 | J2405 | FreseniUS Kabi USA, LLC | 24 × 2 | 96 |
| 00904-6551-61 | Q0162 | Major Pharmaceuticals | 100 | 400 |
| 00904-6552-61 | Q0162 | Major Pharmaceuticals | 100 | 800 |
| 16714-0159-01 | Q0162 | Northstar RxLLC | 30 | 120 |
| 16714-0160-01 | Q0162 | Northstar RxLLC | 30 | 240 |
| 43063-0792-06 | Q0162 | PD-Rx Pharmaceuticals, Inc. | 6 | 48 |
| 50090-3178-00 | Q0162 | A-S Medication Solutions | 10 | 40 |
| 50090-3178-01 | Q0162 | A-S Medication Solutions | 6 | 24 |
| 50090-3178-02 | Q0162 | A-S Medication Solutions | 20 | 80 |
| 50090-3178-04 | Q0162 | A-S Medication Solutions | 3 | 12 |
| 50090-3178-05 | Q0162 | A-S Medication Solutions | 12 | 48 |
| 50090-3185-00 | Q0162 | A-S Medication Solutions | 4 | 32 |
| 50090-6342-00 | Q0162 | A-S Medication Solutions | 10 | 40 |
| 50090-6342-01 | Q0162 | A-S Medication Solutions | 6 | 24 |
| 50090-6342-02 | Q0162 | A-S Medication Solutions | 20 | 80 |
| 50090-6342-05 | Q0162 | A-S Medication Solutions | 12 | 48 |
| 50268-0621-15 | Q0162 | AvPAK | 50 | 200 |
| 50268-0622-15 | Q0162 | AvPAK | 50 | 400 |
| 50268-0647-14 | Q0162 | AvPAK | 40 × 5 | 160 |
| 55111-0153-30 | Q0162 | Dr. Reddy's Laboratories Inc. | 30 | 120 |
| 55111-0154-30 | Q0162 | Dr. Reddy's Laboratories Inc. | 30 | 240 |
| 60687-0252-86 | Q0162 | American Health Packaging | 30 × 5 | 120 |
| 62135-0350-30 | Q0162 | Chartwell | 30 | 120 |
| 62135-0351-05 | Q0162 | Chartwell | 500 | 4000 |
| 62135-0351-30 | Q0162 | Chartwell | 30 | 240 |
| 62135-0555-24 | Q0162 | Chartwell | 20 × 5 | 80 |
| 62135-0555-58 | Q0162 | Chartwell | 50 | 40 |
| 68084-0220-01 | Q0162 | American Health Packaging | 100 | 400 |
| 68084-0221-01 | Q0162 | American Health Packaging | 100 | 800 |
| 68462-0105-30 | Q0162 | Glenmark Pharmaceuticals Inc., USA | 30 | 120 |
| 68462-0106-30 | Q0162 | Glenmark Pharmaceuticals Inc., USA | 30 | 240 |
| 68788-8582-02 | Q0162 | Preferred Pharmaceuticals Inc | 12 | 96 |
| 68788-8582-03 | Q0162 | Preferred Pharmaceuticals Inc | 30 | 240 |
| 68788-8651-01 | Q0162 | Preferred Pharmaceuticals Inc | 10 | 40 |
| 68788-8651-03 | Q0162 | Preferred Pharmaceuticals Inc | 30 | 120 |
| 68788-8651-05 | Q0162 | Preferred Pharmaceuticals Inc | 15 | 60 |
| 68788-9368-01 | Q0162 | Preferred Pharmaceuticals Inc | 10 | 40 |
| 68788-9368-02 | Q0162 | Preferred Pharmaceuticals Inc | 12 | 48 |
| 68788-9402-01 | Q0162 | Preferred Pharmaceuticals Inc | 10 | 80 |
| 72789-0034-12 | Q0162 | PD-Rx Pharmaceuticals, Inc. | 30 | 120 |
Ondansetron HCl: common questions
- What is the HCPCS code for Ondansetron HCl?
- CMS assigns Ondansetron HCl NDCs to 2 HCPCS codes: J2405 (per 1 mg), Q0162 (per 1 mg). Which one applies depends on the product; the table lists each NDC with its code.
- How many J2405 billing units are in a package of Ondansetron HCl?
- CMS lists 4 to 400 billing units per package, depending on the NDC, where one unit is 1 mg. Units to report are based on the dose given, not the package.
- How many Q0162 billing units are in a package of Ondansetron HCl?
- CMS lists 12 to 4,000 billing units per package, depending on the NDC, where one unit is 1 mg. Units to report are based on the dose given, not the package.
- Is J2405 a CPT code?
- No. J2405 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.